MAYA MANN: Open Payments
NPI 1295167807 · EWING, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 75 payments from 14 companies in 2025. Trend: 2023 $858 · 2024 $1,395 · 2025 $1,747
Food & beverage: $1,747
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $653 |
| Lilly USA, LLC | 5 | $183 |
| Axsome Therapeutics, Inc. | 6 | $177 |
| Exact Sciences Corporation | 10 | $155 |
| Novo Nordisk Inc | 10 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| PFIZER INC. | 4 | $67 |
| ABBVIE INC. | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $48 |
Products named: AIRSUPRA, BREZTRI, Auvelity, Cologuard Collection Kit, ZEPBOUND, Wegovy, XIFAXAN, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
